RING: Male Visit Checklist (1162)

Citation: NIH R01AI150360. 2022. Barbara Friedland, MS., Jessica Sales, PhD. Population Council, Emory University.

Study Description: We plan to develop a multipurpose prevention technology (MPT) intravaginal ring (IVR) that releases a safe and effective combination of an estrogen, a progestin, and a non-ARV antiviral agent to prevent pregnancy and HIV infection. The unique IVR could reduce both the emergence of drug-resistant HIV and the concern of potential increased risk of HIV transmission associated with use of a progestin-only contraceptive.

Document Type(s): Research Staff Instructions
Study Type(s): Crossover RCT
Study Method(s): Clinical Qualitative
Geography: Domestic
Study Year: 2022
Project Name: RING

Please complete the form below to download this resource

This field is for validation purposes and should be left unchanged.

This information is for internal data collection within Emory's Center for AIDS Research (CFAR) only. Any identifying information will not be shared externally.

Thank you to our contributing institutions